Terms: = Breast cancer AND JAK2, ENSG00000096968, O60674, JTK10, 3717 AND Clinical Outcome
7 results:
1. jak2 expression is correlated with the molecular and clinical features of breast cancer as a favorable prognostic factor.
Liu Q; Ai B; Kong X; Wang X; Qi Y; Wang Z; Fang Y; Wang J
Int Immunopharmacol; 2021 Jan; 90():107186. PubMed ID: 33290964
[TBL] [Abstract] [Full Text] [Related]
2. The Effect of a Newly Synthesized Ferrocene Derivative against MCF-7 breast cancer Cells and Spheroid Stem Cells through ROS Production and Inhibition of jak2/STAT3 Signaling Pathway.
Nourbakhsh M; Farzaneh S; Taghikhani A; Zarghi A; Noori S
Anticancer Agents Med Chem; 2020; 20(7):875-886. PubMed ID: 31893999
[TBL] [Abstract] [Full Text] [Related]
3. 2-Phenylnaphthyridin-4-one Derivative LYF-11 Inhibits Interleukin-6-mediated Epithelial-to-Mesenchymal Transition
Liu LC; Wu YC; Kuo SC; Ho CT; Way TD; Chen ST
Anticancer Res; 2018 May; 38(5):2849-2859. PubMed ID: 29715108
[TBL] [Abstract] [Full Text] [Related]
4. Spatial Proximity to Fibroblasts Impacts Molecular Features and Therapeutic Sensitivity of breast cancer Cells Influencing clinical outcomes.
Marusyk A; Tabassum DP; Janiszewska M; Place AE; Trinh A; Rozhok AI; Pyne S; Guerriero JL; Shu S; Ekram M; Ishkin A; Cahill DP; Nikolsky Y; Chan TA; Rimawi MF; Hilsenbeck S; Schiff R; Osborne KC; Letai A; Polyak K
Cancer Res; 2016 Nov; 76(22):6495-6506. PubMed ID: 27671678
[TBL] [Abstract] [Full Text] [Related]
5. Prolactin Pro-Differentiation Pathway in Triple Negative breast cancer: Impact on Prognosis and Potential Therapy.
López-Ozuna VM; Hachim IY; Hachim MY; Lebrun JJ; Ali S
Sci Rep; 2016 Aug; 6():30934. PubMed ID: 27480353
[TBL] [Abstract] [Full Text] [Related]
6. Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression.
Sato T; Tran TH; Peck AR; Girondo MA; Liu C; Goodman CR; Neilson LM; Freydin B; Chervoneva I; Hyslop T; Kovatich AJ; Hooke JA; Shriver CD; Fuchs SY; Rui H
Oncogene; 2014 Apr; 33(17):2215-24. PubMed ID: 23708665
[TBL] [Abstract] [Full Text] [Related]
7. Signal transducer and activator of transcription 5A/B in prostate and breast cancers.
Tan SH; Nevalainen MT
Endocr Relat Cancer; 2008 Jun; 15(2):367-90. PubMed ID: 18508994
[TBL] [Abstract] [Full Text] [Related]
